Sandoz completes acquisition of EBEWE Pharma, improving global patient access to affordable injectable cancer medicines
Sandoz to focus on quick and seamless integration for customers and employees
25-Sep-2009 -
Sandoz announced that it has completed its USD 1.3 billion acquisition of EBEWE Pharma's specialty generic injectables business, paving the way for the creation of a global center of excellence in generic oncology injectables.
"We are delighted to combine EBEWE Pharma's portfolio and pipeline of ...
anti-infectives
biopharmaceuticals
generics
+2